Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by fox7mf


T.ONC

RE:RE:Corporate Presentation.

It definitely appears as though legal representation told them to take a more...

January 23, 2023

T.ONC

Corporate Presentation.

It's back up, as reported on Stocktwits. Some minor changes in language...

January 23, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

30% of that $36b, and slap a sold sign on Oncy.

January 21, 2023

T.ONC

Corporate Presentation...

...is presently missing from the Onc homepage. A question of general...

January 18, 2023

T.ONC

RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

$60b is just petulant attempts at mockery. The bashers are here because their...

January 13, 2023

T.ONC

RE:ONCY's "quiet period"

We are indeed in a quiet, along with PFE as they peruse final Bracelet data...

January 11, 2023

T.ONC

RE:RE:RE:$Value to Insiders from a Potential Buyout

My only gripe would be the evidence of countless early stage biotechs (ph 1...

January 11, 2023

T.ONC

RE:RE:RE:$Value to Insiders from a Potential Buyout

Well, in any event, thanks for the work you put in here Proboscises...greatly...

January 10, 2023

T.ONC

RE:RE:$Value to Insiders from a Potential Buyout

I'm hoping outstanding shares aren't at $69m...$64m outstanding at b...

January 10, 2023

T.ONC

RE:RE:Wow - no end date for Goblet

Instead of waiting to hear from the FDA on how to set-up the impending ph3...

January 9, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pfizer pivots to 'externalization" of rare disease programs

It's been established for quite sometime that Buck only spews moronic...

January 8, 2023

T.ONC

RE:RE:RE:RE:ThermoFisher buys oncology diagnostic company for US$2.8 Bln

Who will acquire ONC & when? PFE only has 30-35 days left on their...

January 5, 2023

T.ONC

RE:RE:RE:RE:RE:Just the facts …need to be understood

Great post Proboscises, thank you. I concur with your assessment that a...

December 30, 2022

T.ONC

PFE'S 90 Day Exclusivity....

...on Bracelet-1 data is down to about what, 40-45 days? Tic-tok Pfizer. It...

December 25, 2022

T.ONC

RE:RE:RE:ONCY's pelareorep activates interferon (IFN) signalling

....I'd like to think that valuation will be closer to $15b usd when one...

December 25, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

Quentin doesn't hold any shares. It's kinda counterproductive to hold...

December 23, 2022

T.ONC

RE:Merck USA (MSD) signs US$ 9.3 Billion bio-buck deal

Oncy is ph3 ready for multiple indications...with accelerated approval or...

December 22, 2022

T.ONC

RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

Agreed. Except the onus will be on Roche to seek accelerated approval and/or...

December 21, 2022

T.ONC

RE:RE:Biotech Take Over - Wall Street Journal

With all that ONC brings to the table for a potential acquirer, I could see a...

December 20, 2022

T.ONC

Newbies...ignore the vapid FUD attempts...

...but ask yourself why are bashers proliferating around a discussion board...

December 20, 2022